Australia markets close in 3 hours 7 minutes

Madrigal Pharmaceuticals, Inc. (MDGL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
235.06-7.43 (-3.06%)
At close: 04:00PM EDT
235.76 +0.70 (+0.30%)
After hours: 06:27PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
281,433
272,350
245,441
205,164
184,809
-
Selling general and administrative
172,764
108,146
48,130
37,318
21,864
-
Total operating expenses
454,197
380,496
293,571
242,482
206,673
-
Operating income or loss
-454,197
-380,496
-293,571
-242,482
-206,673
-
Interest expense
14,214
12,712
3,964
0
-
-
Total other income/expenses net
-
-
-
273
100
-
Income before tax
-444,275
-373,630
-295,350
-241,846
-202,244
-
Income from continuing operations
-444,275
-373,630
-295,350
-241,846
-202,244
-
Net income
-444,275
-373,630
-295,350
-241,846
-202,244
-
Net income available to common shareholders
-444,275
-373,630
-295,350
-241,846
-202,244
-
Basic EPS
-19.25
-
-17.23
-14.63
-13.09
-5.45
Diluted EPS
-19.25
-
-17.23
-14.63
-13.09
-5.45
Basic average shares
18,054
-
17,137
16,535
15,447
15,395
Diluted average shares
18,054
-
17,137
16,535
15,447
15,395